サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1400995

肝疾患治療市場：治療タイプ別、疾患タイプ別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年、予測

Liver Disease Treatment Market, by Treatment Type, Disease Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 266 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
肝疾患治療市場：治療タイプ別、疾患タイプ別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年、予測
出版日: 2023年12月17日
発行: AnalystView Market Insights
ページ情報: 英文 266 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

肝疾患治療市場規模は2022年に223億42万米ドルとなり、2023年から2030年にかけてCAGR 6.42%で拡大

肝疾患治療市場力学

肝疾患患者数の増加が市場成長を促進

肝疾患の有病率の増加、アルコール使用量の増加、食習慣の悪化は、肝疾患治療市場の成長を促進すると予測される主な要因です。例えば、2021年6月にClinical Liver Disease誌に掲載された調査報告書によると、慢性肝疾患（CLD）は世界で約15億人が罹患しており、世界的に病気と死亡の主な原因の一つとなっています。さらに、米国肝臓病学会が2021年6月に発表した調査によると、非アルコール性脂肪性肝疾患（NAFLD）が肝疾患の主な原因であり、症例の59％を占め、次いでC型肝炎（9％）、B型肝炎（29％）、アルコール性肝疾患（ALD）（2％）となっています。さらに、2022年10月にClinical and Molecular Hepatology誌に発表された調査では、2040年までに非アルコール性脂肪性肝疾患（NAFLD）の有病率は世界で55.7％になると予測されています。その結果、肝臓疾患の増加が業界全体に拍車をかけています。

肝疾患治療市場 - 主要洞察

当社のリサーチアナリストが共有した分析によると、肝疾患治療の世界市場は予測期間（2023年～2030年）に約6.42％のCAGRで毎年成長すると予測されています。

肝疾患治療市場は、市場成長を促進する肝疾患患者の増加により、著しい速度で成長すると予測される

治療タイプ別では、抗ウイルス薬が2022年に最大市場シェアを示すと予測

疾患タイプ別では、肝炎が2022年の主要疾患タイプです。

地域別では、北米が2022年の売上高をリード

肝疾患治療市場 - セグメンテーション分析：

世界の肝疾患治療市場は、治療タイプ、疾患タイプ、地域に基づいて区分されます。

市場は治療タイプに基づいてカテゴリーに分けられる：免疫抑制剤、抗ウイルス剤、免疫グロブリン、ワクチン、標的療法、副腎皮質ステロイド、化学療法薬。抗ウイルス薬のサブセグメントでは、抗ウイルス薬には多くの利点があるため、この分野への支出が大幅に増加しています。さらに、ヘルスケアコストの上昇、社会的認知度の向上、B型肝炎とC型肝炎の有病率の増加なども、市場拡大を支える重要な要素です。

同市場は、疾患タイプによってカテゴリー分けされている：自己免疫疾患、肝炎、非アルコール性脂肪性肝疾患（NAFLD）、遺伝子疾患、がん、その他。薬剤ミス、アルコールの過剰摂取、自己免疫疾患、ウイルス感染、非アルコール性脂肪性肝炎などにより、過去数年間に肝組織の炎症状態は著しく悪化しています。

肝疾患治療市場 - 地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米地域は成長が見込まれます。2022年、肝疾患治療薬市場は北米が支配的となります。特に中国、インド、韓国では、先進的で革新的な肝疾患治療薬に対するニーズが急速に高まっており、これが業界の発展を後押しする重要な要素の1つとなっています。また、NAFLDや肝炎の有病率の増加、専門知識の不足、医療インフラの貧弱さなどが、この地域の成長の主な要因の1つとなっています。

肝疾患治療市場 - 競合情勢：

企業は、企業ウェブサイト、eコマースウェブサイト、小売業者、流通業者、最終消費者など、さまざまなチャネルを通じて製品を販売しています。製品メーカーは、製品のコスト、性能、製品作り、技術、評判、入手可能性など、さまざまな側面で競争しています。リーチを強化し市場シェアを拡大するために企業が用いる主な製品タイプには、新製品の発売、流通網の開拓、研究開発費、M&Aなどがあります。例えば、2023年1月、武田薬品とArrowhead Pharmaceuticals Inc.は、α-1抗トリプシン欠乏性肝疾患（AATD-LD）治療薬Fazirsiranの臨床第2相試験SEQUOIAのトップラインデータを発表しました。

目次

第1章 肝疾患治療市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 肝疾患治療の主要市場動向

  • 肝疾患治療市場促進要因
  • 肝疾患治療市場抑制要因
  • 肝疾患治療市場の機会
  • 肝疾患治療市場の今後の動向

第4章 肝疾患治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 肝疾患治療市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 肝疾患治療市場情勢

  • 肝疾患治療市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 肝疾患治療市場 - 治療タイプ別

  • 概要
    • 治療タイプ別のセグメントシェア分析
    • 免疫抑制剤
    • 抗ウイルス薬
    • 免疫グロブリン
    • ワクチン
    • 標的療法
    • コルチコステロイド
    • 化学療法薬

第8章 肝疾患治療市場 - 疾患タイプ別

  • 概要
    • 疾患別セグメントシェア分析
    • 自己免疫疾患
    • 肝炎
    • 非アルコール性脂肪肝疾患（NAFLD）
    • 遺伝性疾患
    • がん
    • その他

第9章 肝疾患治療市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析 - 肝疾患治療業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Vertex Pharmaceuticals
    • Takeda Pharmaceuticals
    • Shire（now part of Takeda Pharmaceuticals）
    • Roche
    • Pfizer
    • Novartis
    • Madrigal Pharmaceuticals
    • Intercept Pharmaceuticals
    • Gilead Sciences
    • Genfit
    • Durect Corporation
    • Conatus Pharmaceuticals
    • Bristol-Myers Squibb
    • Alnylam Pharmaceuticals
    • Allergan

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Liver Disease Treatment Market: Treatment Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment Type
  • TABLE Global Liver Disease Treatment Market, by Treatment Type 2018-2030 (USD Million)
  • TABLE Liver Disease Treatment Market: Disease Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Liver Disease Treatment Market, by Disease Type 2018-2030 (USD Million)
  • TABLE Liver Disease Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Liver Disease Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE North America Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Europe Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Latin America Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Treatment Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Liver Disease Treatment Market, by Disease Type, 2018-2030 (USD Million)

List of Figures

  • FIGURE Liver Disease Treatment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Treatment Type segment market share analysis, 2022 & 2030
  • FIGURE Treatment Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Disease Type segment market share analysis, 2022 & 2030
  • FIGURE Disease Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Europe Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Asia Pacific Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Latin America Liver Disease Treatment Market share and leading players, 2022
  • FIGURE Middle East and Africa Liver Disease Treatment Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE Germany Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE India Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE Brazil Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Liver Disease Treatment Market share analysis by country, 2022
  • FIGURE Saudi Arabia Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Liver Disease Treatment Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1959

REPORT HIGHLIGHT

Liver Disease Treatment market size was valued at USD 22,300.42 Million in 2022, expanding at a CAGR of 6.42% from 2023 to 2030.

Treatment for liver disease refers to medical measures taken to control and lessen illnesses that have an impact on the structure or operation of the liver. Depending on the exact liver ailment, several treatment modalities are used, but they often entail modifying one's lifestyle, taking medications, and in extreme circumstances, undergoing surgery or a liver transplant. Hepatitis, cirrhosis, fatty liver disease, and liver cancer are examples of common liver illnesses. Controlling inflammation, treating symptoms, avoiding consequences, and addressing underlying causes are frequently the objectives of treatment. To improve results and maintain liver function, early diagnosis, and prompt treatments are essential.

Liver Disease Treatment Market Dynamics

The rise in the number of people with liver diseases propelled the market growth

The increased prevalence of liver disorders, the rise in alcohol usage, and poor eating habits are the main factors anticipated to propel growth in the market for therapies for liver diseases. For instance, according to a research report that was published in the Clinical Liver Disease journal in June 2021, chronic liver disease (CLD), which affects nearly 1.5 billion people worldwide, is one of the major causes of sickness and mortality globally. Furthermore, according to research published in June 2021 by the American Association for the Study of Liver Diseases, non-alcoholic fatty liver disease (NAFLD) is the leading cause of hepatic illness, accounting for 59% of cases, followed by hepatitis C (9%), hepatitis B (29%), and alcoholic liver disease (ALD) (2%). Furthermore, a research published in Clinical and Molecular Hepatology in October 2022 predicted that by 2040, the prevalence of non-alcoholic fatty liver disease (NAFLD) will be 55.7% worldwide. As a result, rising liver ailments have fueled the industry as a whole.

Liver Disease Treatment Market- Key Insights

As per the analysis shared by our research analyst, the Global Liver Disease Treatment market is estimated to grow annually at a CAGR of around 6.42% over the forecast period (2023-2030)

The Liver Disease Treatment market is projected to grow at a significant rate due to the rise in the number of people with liver diseases to propel the market growth

Based on Treatment Type segmentation, Antiviral Drugs was predicted to show maximum market share in the year 2022

Based on Disease Type segmentation, Hepatitis was the leading Disease Type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Liver Disease Treatment Market- Segmentation Analysis:

The Global Liver Disease Treatment market is segmented on the basis of Treatment Type, Disease Type, and Region.

The market is divided into categories based on Treatment Type: Immunosuppressants, Antiviral Drugs, Immunoglobulins, Vaccines, Targeted Therapy, Corticosteroids, and Chemotherapy Drugs. Positive effects are being produced on the antiviral drug's sub-segment by the significantly increasing expenditures in the sector, largely because of its numerous advantages. Additionally, rising healthcare costs, increased public awareness, and an increase in the prevalence of hepatitis B and C are other significant aspects anticipated to support market expansion.

The market is divided into categories based on Disease Type: Autoimmune Diseases, Hepatitis, Non-alcoholic Fatty Liver Disease (NAFLD), Genetic Disorders, Cancer, and Others. Due to pharmaceutical mistakes, excessive alcohol intake, autoimmune disorders, viral infections, and nonalcoholic steatohepatitis, the inflammatory status of the liver tissue has significantly worsened during the past several years.

Liver Disease Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America region is expected to grow. In 2022, the market for Liver Disease Treatments will be dominated by North America. The extensively increasing need for advanced and innovative liver disease therapeutics particularly in China, India, and South Korea is one of the key elements boosting the development of the industry. Also, one of the major factors behind this growth can be the increasing prevalence of NAFLD and hepatitis, lack of expertise, and the poor healthcare infrastructure in the region.

Liver Disease Treatment Market- Competitive Landscape:

Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary Types used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in January 2023, Topline data from the Phase 2 SEQUOIA clinical research of experimental Fazirsiran for the treatment of liver disease linked to alpha-1 antitrypsin deficiency (AATD-LD) were released by Takeda and Arrowhead Pharmaceuticals Inc.

Recent Developments:

In June 2023, according to Ipsen, individuals with Alagille syndrome (ALGS) starting at 12 months of age can now treat their cholestatic pruritus with Bylvay® (odevixibat), as to an FDA approval. Bylvay is a once-daily, minimally systemically exposed, locally acting ileal bile acid transport inhibitor (IBATi) with minimum systemic exposure. In the United States and Europe, Bylvay was authorized as the first medication for treating cholestatic pruritus in individuals with progressive familial intrahepatic cholestasis (PFIC) in 2021. For qualifying ALGS patients, Bylvay is instantly available with a prescription.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVER DISEASE TREATMENT MARKET KEY PLAYERS

  • Vertex Pharmaceuticals
  • Takeda Pharmaceuticals
  • Shire (now part of Takeda Pharmaceuticals)
  • Roche
  • Pfizer
  • Novartis
  • Madrigal Pharmaceuticals
  • Intercept Pharmaceuticals
  • Gilead Sciences
  • Genfit
  • Durect Corporation
  • Conatus Pharmaceuticals
  • Bristol-Myers Squibb
  • Alnylam Pharmaceuticals
  • Allergan

GLOBAL LIVER DISEASE TREATMENT MARKET, BY TREATMENT TYPE

  • Immunosuppressants
  • Antiviral Drugs
  • Immunoglobulins
  • Vaccines
  • Targeted Therapy
  • Corticosteroids
  • Chemotherapy Drugs

GLOBAL LIVER DISEASE TREATMENT MARKET, BY DISEASE TYPE

  • Autoimmune Diseases
  • Hepatitis
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Genetic Disorders
  • Cancer
  • Others

GLOBAL LIVER DISEASE TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Liver Disease Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Liver Disease Treatment Market Snippet by Treatment Type
    • 2.1.2. Liver Disease Treatment Market Snippet by Disease Type
    • 2.1.3. Liver Disease Treatment Market Snippet by Country
    • 2.1.4. Liver Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Semiconductor Memory Key Market Trends

  • 3.1. Liver Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Liver Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Liver Disease Treatment Market Opportunities
  • 3.4. Liver Disease Treatment Market Future Trends

4. Semiconductor Memory Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Liver Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Liver Disease Treatment Market Landscape

  • 6.1. Liver Disease Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Liver Disease Treatment Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
    • 7.1.2. Immunosuppressants
    • 7.1.3. Antiviral Drugs
    • 7.1.4. Immunoglobulins
    • 7.1.5. Vaccines
    • 7.1.6. Targeted Therapy
    • 7.1.7. Corticosteroids
    • 7.1.8. Chemotherapy Drugs

8. Liver Disease Treatment Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2022 & 2030 (%)
    • 8.1.2. Autoimmune Diseases
    • 8.1.3. Hepatitis
    • 8.1.4. Non-alcoholic Fatty Liver Disease (NAFLD)
    • 8.1.5. Genetic Disorders
    • 8.1.6. Cancer
    • 8.1.7. Others

9. Liver Disease Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Semiconductor Memory Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Semiconductor Memory Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Semiconductor Memory Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Semiconductor Memory Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Semiconductor Memory Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Disease Type, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Semiconductor Memory Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Vertex Pharmaceuticals
    • 10.2.2. Takeda Pharmaceuticals
    • 10.2.3. Shire (now part of Takeda Pharmaceuticals)
    • 10.2.4. Roche
    • 10.2.5. Pfizer
    • 10.2.6. Novartis
    • 10.2.7. Madrigal Pharmaceuticals
    • 10.2.8. Intercept Pharmaceuticals
    • 10.2.9. Gilead Sciences
    • 10.2.10. Genfit
    • 10.2.11. Durect Corporation
    • 10.2.12. Conatus Pharmaceuticals
    • 10.2.13. Bristol-Myers Squibb
    • 10.2.14. Alnylam Pharmaceuticals
    • 10.2.15. Allergan

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us